Lymphocele disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: LYM005 MIFTS: 35	Lymphocele Categories: Immune diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Lymphocele

MalaCards integrated aliases for Lymphocele:

Name: Lymphocele ¹² ⁴³ ¹⁵ ⁷¹

Lymphocele Adverse Event ⁷¹

Lymph Cyst ¹²

Classifications:

MalaCards categories:
Anatomical: Immune diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:4347

MeSH ⁴³ D008210

NCIt ⁴⁹ C78442

SNOMED-CT ⁶⁷ 12167004

UMLS ⁷¹ C0024248 C1963162

Sources

Summaries for Lymphocele

MalaCards based summary : Lymphocele, also known as lymphocele adverse event, is related to acute kidney tubular necrosis and campomelia, cumming type. An important gene associated with Lymphocele is KLK3 (Kallikrein Related Peptidase 3). The drugs Heparin and Calcium have been mentioned in the context of this disorder. Affiliated tissues include kidney, lymph node and prostate, and related phenotypes are Decreased viability and Decreased viability

Wikipedia : ⁷⁴ A lymphocele is a collection of lymphatic fluid within the body not bordered by epithelial lining. It is... more...

Sources

Related Diseases for Lymphocele

Diseases related to Lymphocele via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 139)

#	Related Disease	Score	Top Affiliating Genes
1	acute kidney tubular necrosis	30.4	CABIN1 ALB
2	campomelia, cumming type	12.2
3	hydronephrosis	10.5
4	lymphedema	10.4
5	submandibular gland cancer	10.4	KLK3 CABIN1
6	endometrial cancer	10.4
7	cervical carcinosarcoma	10.3	MAPK8IP2 MAPK8IP1
8	thrombophilia due to thrombin defect	10.3
9	ureteral obstruction	10.3
10	end stage renal failure	10.3
11	ileus	10.3
12	cervix small cell carcinoma	10.3	MAPK8IP2 MAPK8IP1
13	papillary squamous carcinoma	10.3	MAPK8IP2 MAPK8IP1
14	female urethral cancer	10.3	KLK3 ERVMER34-1
15	sigmoid disease	10.3	MAPK8IP2 MAPK8IP1
16	cervical incompetence	10.3	PTPRN MAPK8IP1
17	vaginal cancer	10.3	MAPK8IP2 MAPK8IP1
18	urinary tract obstruction	10.2
19	vaginal discharge	10.2	MAPK8IP2 MAPK8IP1
20	hypertensive encephalopathy	10.2	CABIN1 ALB
21	pyuria	10.2	KLK3 ALB
22	ovarian cancer	10.2
23	ascites, chylous	10.2
24	cervical cancer	10.2
25	hydrops, lactic acidosis, and sideroblastic anemia	10.2
26	pulmonary embolism	10.2
27	uterus carcinoma in situ	10.2	PTPRN MAPK8IP1
28	corticosteroid allergy	10.2	CABIN1 ALB
29	hemorrhoid	10.2	KLK3 ALB
30	cervix uteri carcinoma in situ	10.2	PTPRN MAPK8IP1
31	hantavirus hemorrhagic fever with renal syndrome	10.2	CABIN1 ALB
32	oxirane allergy	10.1	ERVMER34-1 ALB
33	suppressor of tumorigenicity 3	10.1
34	lymphoproliferative syndrome	10.1
35	47,xyy	10.1
36	back pain	10.1
37	radiation cystitis	10.1	MAPK8IP2 MAPK8IP1 KLK3
38	pneumocystosis	10.1	CABIN1 ALB
39	paralytic ileus	10.1	ERVMER34-1 ALB
40	pyelitis	10.1	CABIN1 ALB
41	pelvic varices	10.1	KLK3 ALB
42	isthmus cancer	10.0	PTPRN MAPK8IP2 MAPK8IP1
43	aortic aneurysm, familial abdominal, 1	10.0
44	bladder cancer	10.0
45	lipomatosis, multiple	10.0
46	microvascular complications of diabetes 3	10.0
47	microvascular complications of diabetes 4	10.0
48	microvascular complications of diabetes 6	10.0
49	microvascular complications of diabetes 7	10.0
50	scoliosis	10.0

Graphical network of the top 20 diseases related to Lymphocele:

Sources

Symptoms & Phenotypes for Lymphocele

GenomeRNAi Phenotypes related to Lymphocele according to GeneCards Suite gene sharing:

²⁶ (show all 11)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased viability	GR00055-A-2	9.84	MTOR
2	Decreased viability	GR00173-A	9.84	MAPK8IP1
3	Decreased viability	GR00221-A-1	9.84	MTOR STK10
4	Decreased viability	GR00221-A-2	9.84	MAPK8IP2 STK10
5	Decreased viability	GR00221-A-3	9.84	STK10
6	Decreased viability	GR00221-A-4	9.84	MTOR MAPK8IP1
7	Decreased viability	GR00301-A	9.84	MAPK8IP1
8	Decreased viability	GR00342-S-1	9.84	MAPK8IP2 MTOR STK10
9	Decreased viability	GR00342-S-2	9.84	MTOR STK10
10	Decreased viability	GR00342-S-3	9.84	MAPK8IP2 STK10 MAPK8IP1
11	Decreased viability	GR00402-S-2	9.84	MAPK8IP2 MTOR STK10 MAPK8IP1

Sources

Drugs & Therapeutics for Lymphocele

Drugs for Lymphocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Heparin

Approved, Investigational

Phase 4

9005-49-6

772 46507594

Synonyms:

101921-26-0

102785-31-9

102-94-3

104521-37-1

11078-24-3

11129-39-8

12656-11-0

37324-73-5

9041-08-1

9045-22-1

9075-96-1

913079-23-9

91449-79-5

AC1L1ROY

ALFA 87-120

ALFA 87-163

ALFA 87-198

ALFA 87-81

ALFA 88-247

Allocinnamic acid

alpha-Heparin

Alpha-Heparin

Ardeparin

Ardeparin sodium

Ariven

Arteven

Bemiparin

Bemiparin sodium

Calcilean

Calciparine

Certoparin

CID8784

cis-.beta.-Carboxystyrene

cis-Cinnamic acid

Clexane

Clivarin

Clivarine

CY 216

Cy 222

Dalteparin

Dalteparin sodium

Depo-Heparin

EINECS 232-681-7

Enoxaparin

Enoxaparin sodium

Eparina

Eparina [DCIT]

Fluxum

FR 860

Fragmin A

Fragmin B

Fragmin IV

Fraxiparin

H 2149

Hed-heparin

Hed-Heparin

Hep Flush Kit in plastic container

Hepalean

heparin

Heparin Cy 216

Heparin CY 216

Heparin Leo

Heparin Lock Flush

Heparin Lock Flush in plastic container

Heparin Lock Flush preservative free

Heparin Lock Flush preservative free in plastic container

Heparin natrium

Heparin sodium

Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 1,000 units in dextrose 5% in plastic container

Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 10,000 units in dextrose 5%

Heparin sodium 10,000 units in dextrose 5% in plastic container

Heparin sodium 10,000 units in sodium chloride 0.45%

Heparin sodium 10,000 units in sodium chloride 0.9%

Heparin sodium 12,500 units in dextrose 5%

Heparin sodium 12,500 units in dextrose 5% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.9%

Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 2,000 units in dextrose 5% in plastic container

Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 20,000 units and dextrose 5% in plastic container

Heparin sodium 20,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units and dextrose 5% in plastic container

Heparin sodium 25,000 units in dextrose 5%

Heparin sodium 25,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.9%

Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units in dextrose 5% in plastic container

Heparin sodium 5,000 units in sodium chloride 0.45%

Heparin sodium 5,000 units in sodium chloride 0.9%

Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container

Heparin sodium in plastic container

Heparin sodium preservative Free

Heparin sodium salt

Heparin sulfate

Heparin sulphate

Heparin, sodium salt

Heparina

Heparina [INN-Spanish]

Heparinate

Heparine

Heparine [INN-French]

Heparinic acid

Heparinsodiumsalt

Heparinum

Heparinum [INN-Latin]

Heparinum natricum

Hepathrom

Hepflush-10

Hep-Lock

Hep-Lock U/P

HSDB 3094

Innohep

Inno-Hep

Isocinnamic acid

Kabi 2165

KB 101

Leparan

LHN 1

Lioton 1000

Lipo-hepin

Lipo-Hepin

Liquaemin

Liquaemin Lock Flush

Liquaemin Sodium

Liquaemin sodium preservative free

Liquemin

Logiparin

Low molecular weight heparin sodium

Minolteparin sodium

MolPort-003-760-257

Multiparin

Nadroparin

Nadroparine

Novoheparin

NSC174025

Octaparin

OP 386

OP 622

Pabyrin

Panheprin

Parnaparin

Parnaparin sodium

Parvoparin

Pularin

Reviparin

Reviparin sodium

Ro 11

Sandoparin

Sodium acid heparin

Sodium heparin

Sodium heparinate

Subeparin

Sublingula

Thromboliquine

Tinzaparin

Tinzaparin sodium

Triofiban

Unfractionated heparin

UNII-12M44VTJ7B

UNII-3S182ET3UA

UNII-E47C0NF7LV

UNII-T2410KM04A

UNII-ZZ45AB24CA

Vetren

Vitrum AB

WY 90493RD

Calcium

Approved, Nutraceutical

Phase 4

7440-70-2

271

Synonyms:

Blood coagulation factor XIII

Ca(2+)

Ca2+

Calcio

Calcium

Calcium element

CALCIUM ion

Calcium, doubly charged positive ion

Calcium, elemental

Coagulation factor XIII

Elemental calcium

Factor XIII

Factor XIII a chain

Factor XIII a-chain

Factor XIII transamidase

Factor XIII, coagulation

Fibrin stabilizing factor

Fibrinase

Kalzium

Laki lorand factor

Laki-lorand factor

Stabilizing factor, fibrin

Transamidase, factor XIII

XIII, coagulation factor

Hemostatics

Phase 4

Coagulants

Phase 4

Fibrinolytic Agents

Phase 4

Anticoagulants

Phase 4

Calcium, Dietary

Phase 4

calcium heparin

Phase 4

lanreotide

Approved

Phase 3

108736-35-2

Somatostatin

Approved, Investigational

Phase 3

51110-01-1, 38916-34-6

53481605

Cisplatin

Approved

Phase 3

15663-27-1

84093 441203 2767

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

Carboquone

CDDP

CHEBI:35852

CID441203

Cis Pt II

cis-[PtCl2(NH3)2]

cis-DDP

Cis-DDP

Cis-Diaminedichloroplatinum

cis-diamminedichloridoplatinum(II)

cis-Diamminedichloroplatinum

Cis-Diamminedichloroplatinum

cis-diamminedichloroplatinum(II)

cis-Dichlorodiammineplatinum(II)

Cismaplat

Cisplatin

Cisplatine

cisplatino

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

CPD0-1392

CPDC

CPDD

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

nchembio773-comp1

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

trans-DDP

Trans-DDP

Trans-Diaminedichloroplatinum

trans-diamminedichloridoplatinum(II)

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

Angiopeptin

Phase 3

Hormone Antagonists

Phase 3

Hormones

Phase 3

Fibrin Tissue Adhesive

Phase 3

Pasireotide

Approved

Phase 2

396091-73-9

9941444

Octreotide

Approved, Investigational

83150-76-9

6400441 383414

Synonyms:

(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

79517-01-4 (acetate salt)

83150-76-9

AC1L1GVU

AC1L8LCD

AC1L9M4X

C07306

C5H12O2.C4H10

CHEBI:427278

CHEBI:611465

CHEMBL1680

CID383414

CID448601

CID54374

Compound 201 995

Compound 201995

Compound 201-995

D00442

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide

DRG-0115

HMS2090C09

HS-2020

L000453

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*

Longastatin

LS-177735

LS-187135

NCGC00181796-01

nchembio.184-comp3

NCI60_025753

Octreotida

Octreotida [Spanish]

Octreotide

Octreotide (USAN/INN)

Octreotide [USAN:INN:BAN]

Octreotide acetate

Octreotide acetate salt

Octreotide Acetate Salt

Octreotide-LAR

Octreotidum

Octreotidum [Latin]

Octrotide

SAN 201-995

Sandostatin

Sandostatine

Sandoz 201 995

Sandoz 201995

Sandoz 201-995

SM 201-995

SMS 201-995

SMS-201-995

UNII-RWM8CCW8GP

zacycloicosane-4-carboxamide acetate

Pharmaceutical Solutions

Antineoplastic Agents, Hormonal

Interventional clinical trials:

(show all 37)

#	Name	Status	NCT ID	Phase	Drugs
1	A Randomized Control Trial for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection	Completed	NCT02476357	Phase 4
2	Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.	Completed	NCT02001857	Phase 4	1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.
3	Does Intraoperative Application of TachoSil Reduce the Number of Lymphocele After Pelvic Lymphadenectomy?	Completed	NCT03752606	Phase 4
4	A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)	Completed	NCT03006562	Phase 4	Subcutaneous Heparin
5	Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer: a Pilot Study	Unknown status	NCT01974193	Phase 3	Floseal
6	A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial	Completed	NCT01470677	Phase 3	Tachosil fibrin patch
7	Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer	Completed	NCT00630695	Phase 3	Lanreotide LP 90;Placebo lanreotide
8	Efficacy of a Fibrin Sealant (Tissucol Duo®) for the Prevention of Lymphocele After Laparoscopic Pelvic Lymphadenectomy Due to Gynaecological Cancer: a Randomised Controlled Trial	Completed	NCT03914963	Phase 3
9	Application of the Biological Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplant	Completed	NCT01631448	Phase 3
10	Observation Versus Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer: A Phase 3 Prospective Multi-institutional Randomised Controlled Trial	Recruiting	NCT03071289	Phase 3	Cisplatin
11	Evaluation of the Effect of Pasireotide LAR Administration in the Lymphocele Prevention After Axillary Node Dissection for Breast Cancer	Completed	NCT01356862	Phase 2	PASIREOTIDE;PLACEBO
12	PREvention of Post-mastectomy LYMphoceles by PAdding. A Randomized Prospective Multicenter Study	Unknown status	NCT02894021
13	Prospective Randomized Trial on Laparoscopic Radical Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Early Stage Cervical Cancer (FIGO Stages IA2-IB1-IIA<2cm) and Advanced Stage Cervical Cancer (FIGO Stages IB2-IIA>2 Cm-IIB) Submitted to NACT With Complete Clinical Response: Thunderbeat Technology Versus Standard Bipolar Electro Surgery	Unknown status	NCT01717781
14	Prospective Randomized Trial on Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II: Thunderbeat Technology Versus Standard Bipolar Electro-surgery.	Unknown status	NCT01717794
15	Assistant Lecturer of Urology in Assiut University	Unknown status	NCT03338140
16	THE ROLE OF FLOSEAL IN THE PREVENTION OF LYMPHOCELE AND LYMPHATIC ASCITES AFTER LYMPH NODE DISSECTION FOR GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL	Completed	NCT01679483		FloSeal application
17	Prospective Open Randomized Study to Evaluate the Efficiency of Prophylactic Fenestration of the Peritoneum in Kidney Transplantation in Preventing the Occurrence of Postoperative Lymphoceles	Completed	NCT01206868
18	Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecological Cancer	Completed	NCT03765320
19	Application of Cold Plasma Energy for Reduction of Lymphoceles Following Pelvic Lymph Node Dissection During Robot-Assisted Radical Prostatectomy	Completed	NCT02658851
20	A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer	Completed	NCT02035475
21	A Randomized Study Evaluating the Efficacy of the Synthetic Adhesive Solution Ifabond, in Reducing Seroma Formation Post Surgery in Breast Cancer Patients, When Used in Partial Mastectomy With or Without Axillary Lymph Node Dissection	Completed	NCT01742975
22	Routine Use of Fibrin Sealant Does Not Reduce Postoperative Wound Complications in Patients Undergoing Renal Transplantation: A Randomized Controlled Trial	Completed	NCT00910052
23	The Impact of Bipolar Energy Modalities on Peri-operative Outcome During Laparoscopic Staging Surgery of Gynecologic Cancers: A Randomized Clinical Trial	Completed	NCT02822820
24	Prevalence, Complications and Risk Factors for Lymphedema After Pelvic and Paraaortic Lymphadenectomy in Primary Radical Surgery for Early Stage Endometrial Carcinoma.	Completed	NCT02115477
25	Prospective Randomized Trial on2D Versus 3D Laparoscopic Radical Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Early Stage Cervical Cancer (FIGO Stages IA2-IB1-IIA<2cm) and Advanced Stage Cervical Cancer (FIGO Stages IB2-IIA>2 Cm-IIB) Submitted to NACT With Complete Clinical Response.	Completed	NCT02320578
26	Study to Evaluate the Efficacy of Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer and Implantation of the Protocol	Completed	NCT03917771
27	Prospective Randomized Trial on 2D Versus 3D Laparoscopic Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II	Completed	NCT02320565
28	Whole Body Bone Scan vs 18F-Choline PET/CT, Better Detection of Bone Metastases in Prostate Cancer Patients, PROSTAGE I	Completed	NCT02232685
29	Choline PET/CT vs. Dual Time Point FDG PET/CT. Better Detection of Bone and Lymph Node Metastasis in Prostate Cancer Patients, PROSTAGE II	Completed	NCT02232724
30	Management of Symptomatic Post-operative Lymphocele With an Patient-controlled, Vascular Catheter: A Validation Study	Recruiting	NCT02800980
31	The Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy	Recruiting	NCT03567525
32	A Prospective Observational Trial on Sentinel Lymph Node Biopsy in Patients With Early Stage Cervical Cancer	Recruiting	NCT02494063
33	PREventive Effect of FENestration With and Without Clipping on Post-Kidney Transplantation Lymphatic Complications: PREFEN Trial	Not yet recruiting	NCT03682627
34	Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection: a Randomized Controlled Trial	Not yet recruiting	NCT04185922
35	Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation In Patients With Breast Cancer	Terminated	NCT03791736
36	A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Micorporous Polysaccharide Hemosphere Particles During Robotic Assisted Prostatectomy With Lymph Node Dissection	Terminated	NCT01644136
37	Choline PET/CT vs. MeAIB PET/CT. Better Detection of Bone and Lymph Node Metastases in Prostate Cancer Patients, PROSTAGE III	Withdrawn	NCT02232672

Search NIH Clinical Center for Lymphocele

Cochrane evidence based reviews: lymphocele

Sources

Genetic Tests for Lymphocele

Sources

Anatomical Context for Lymphocele

MalaCards organs/tissues related to Lymphocele:

⁴⁰

Kidney, Lymph Node, Prostate, Breast, Bone, Liver, Heart

Sources

Publications for Lymphocele

Articles related to Lymphocele:

(show top 50) (show all 1134)

#	Title	Authors	PMID	Year
1	Predictors of symptomatic lymphocele after kidney transplantation. ⁶¹	Joosten M...Poyck PP	31486950	2019
2	Surgical strategies for lymphocele prevention in minimally-invasive radical prostatectomy and lymph-node dissection: a systematic review. ⁶¹	Motterle G...Dal Moro F	31797684	2019
3	[Robot-assisted kidney transplantation]. ⁶¹	Zeuschner P...Stockle M	31832746	2019
4	ABO-incompatible living-donor kidney transplantation: Study of 48 patients after desensitisation. ⁶¹	Fernandez Rivera C...Alonso Hernandez A	31208833	2019
5	Treatment of lymphocele with negative pressure wound therapy post inguinal mass excision: A case-report. ⁶¹	Focassio CCM...Dornas VLBL	31790951	2019
6	A case of laparoscopic fenestration surgery for pelvic lymphocele occurring after laparoscopic radical prostatectomy. ⁶¹	Oyama H...Yasui T	31788150	2019
7	Prophylactic abdominal or retroperitoneal drain placement in major uro-oncological surgery: a systematic review and meta-analysis of comparative studies on radical prostatectomy, cystectomy and partial nephrectomy. ⁶¹	Kowalewski KF...Kriegmair MC	31664510	2019
8	[Diagnosis and treatment of complications related with lymph-node dissection surgery: Lymphorrea, lymphocele and lymphedema.] ⁶¹	Gomez-Ferrer Lozano A	31579044	2019
9	Indocyanine green-enhanced fluorescence-guided video-assisted axillary surgery for chronic lymphocele. ⁶¹	Mazza M...Sommariva A	30549254	2019
10	Bilateral abdominopelvic lymphoceles secondary to huge uterine leiomyomas: A case report. ⁶¹	Al-Shukri M...Al-Qassabi B	31642137	2019
11	Efficacy and Safety of Lateral Approach-Video Endoscopic Inguinal Lymphadenectomy (L-VEIL) over Open Inguinal Block Dissection: a Retrospective Study. ⁶¹	Nayak SP...Vijayakumar M	31496610	2019
12	Robotic-assisted kidney transplant: a single center experience with median follow-up of 2.8 years. ⁶¹	Ganpule A...Desai M	31489478	2019
13	Sentinel lymph node biopsy in patients with malignant melanoma: analysis of post-operative complications. ⁶¹	Solari N...Cafiero F	31368164	2019
14	Effect of Autologous Fibrin Glue on Lymphatic Drainage and Lymphocele Formation in Extended Bilateral Pelvic Lymphadenectomy in Robot-Assisted Radical Prostatectomy. ⁶¹	Garayev A...Atug F	31187653	2019
15	Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer. ⁶¹	Gornes H...Vaysse C	31088723	2019
16	[Radical vulvectomy and inguinal lymphadenectomy using a single incision for the treatment of vulvar malignancy]. ⁶¹	Wang YF...Feng WQ	31434426	2019
17	Full Robot-Assisted Living Donor Nephrectomy and Kidney Transplantation in a Twin Dedicated Operating Room: Initial Experience From a High-Volume Robotic Center. ⁶¹	Siena G...Serni S	31018770	2019
18	A Novel Technique of Dual Kidney Transplantation (DKT) From Adult Donors. ⁶¹	Seth A...Kenwar DB	31051165	2019
19	Nonovarian Mimics of Ovarian Malignancy. ⁶¹	Shetty M	31375172	2019
20	Incidence of and risk factors for lymphocele formation after lateral pelvic lymph node dissection for rectal cancer: a retrospective study. ⁶¹	Ochiai K...Ishihara S	31454448	2019
21	Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation. ⁶¹	Janigen BM...Pisarski P	31456076	2019
22	Can we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)? ⁶¹	Seetharam Bhat KR...Patel VR	31422556	2019
23	Risk factors, complications and management of lymphocele formation after radical prostatectomy: A mini-review. ⁶¹	Tsaur I...Thomas C	30939628	2019
24	Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. ⁶¹	Abeling T...Gwinner W	29860340	2019
25	Efficacy of a Fibrin Sealant (Tissucol Duo) for the Preventionof Lymphocele after Laparoscopic Pelvic Lymphadenectomy:A Randomized Controlled Trial. ⁶¹	Jaunarena I...Lekuona A	30296475	2019
26	[Use of Vacuum-Assisted Closure Therapy in the Treatment of Postoperative Inguinal Lymphocele after Lymphadenectomy for a Vulvar Apocrine Adenocarcinoma : A Case Report]. ⁶¹	Yamada Y...Ito N	31501398	2019
27	Surgical Complications in Kidney Transplantation: An Overview of a Portuguese Reference Center. ⁶¹	Carvalho JA...Figueiredo A	31155198	2019
28	Cost-minimization study of the percutaneous approach to endovascular aortic aneurysm repair. ⁶¹	Hong JC...Chen JC	31176637	2019
29	Lymphangiography and Lymphatic Embolization for the Management of Pelvic Lymphocele After Radical Prostatectomy in Prostatic Cancer. ⁶¹	Chu HH...Park S	30919025	2019
30	Factors Influencing Lymphocele Development After Kidney Transplant: Single Center Experience. ⁶¹	Isiktas Sayilar E...Vuruskan H	31250740	2019
31	Transposition of the left vertebral artery during endovascular stent-graft repair of the aortic arch. ⁶¹	Piffaretti G...Bellosta R	31301891	2019
32	Sentinel node navigation surgery in cervical and endometrial cancer: a review. ⁶¹	Niikura H...Yaegashi N	31070770	2019
33	Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: A systematic review and meta-analysis. ⁶¹	Hu J...Zu X	31145338	2019
34	Lymphatic supermicrosurgery for the treatment of recurrent lymphocele and severe lymphorrhea. ⁶¹	Giacalone G...Koshima I	30767257	2019
35	Perinephric transplant fluid collection approach and management. ⁶¹	Alshamsi I...Halawa A	31249219	2019
36	Tissue sealants for the prevention of lymphoceles after radical inguinal lymph node dissection in patients with melanoma: A systematic review and individual patient data meta-analysis. ⁶¹	Gerken ALH...Herrle F	30674074	2019
37	Reduction of lymphocele rate in patients undergoing sentinel node biopsy for melanoma by intraoperative placement of plant-based hemostatic powder: Results of a prospective trial. ⁶¹	Luong J...Vetto JT	30799018	2019
38	Actinomyces odontolyticus infection 3 months post-robotic-assisted laparoscopic prostatectomy. ⁶¹	Clyde M...Ahmad I	30981988	2019
39	The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies: A systematic review and meta-analysis of randomized controlled trials. ⁶¹	Prodromidou A...Kalinoglou N	30660344	2019
40	Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis. ⁶¹	Thomas C...Tsaur I	30796729	2019
41	Treatment of varicose veins, international consensus on which major complications to discuss with the patient: A Delphi study. ⁶¹	de Mik SM...Ubbink DT	30012048	2019
42	Unusual lymphocele following radical cystectomy with orthotopic neobladder. ⁶¹	Kallappan S...Ganesapandi T	31000926	2019
43	The transposed femoral vein arteriovenous fistula for hemodialysis. ⁶¹	Soderman M...Clausen LL	30073914	2019
44	Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy. ⁶¹	Weinberger V...Zikan M	30910151	2019
45	Initial experience of video endoscopic inguinal Lymphadenectomy in a center located at northeast brazilian region. ⁶¹	Meneses AD...Tobias-Machado M	30676302	2019
46	Toward sutureless laparoscopic inguinal hernia repair in children? ⁶¹	Marte A...Esposito V	30896137	2019
47	Prevention of lymphorrhea in aortic lymphadenectomy. ⁶¹	Gorostidi M...Lekuona A	30833448	2019
48	Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study. ⁶¹	Chen HH...Hsiao SM	30875912	2019
49	Indocyanine Green as a Beacon Light in Laparoscopy: A New Application in Transplant Surgery: A Case Report. ⁶¹	Ietto G...Carcano G	30879583	2019
50	Comparison Between Bipolar Lymphatic Vessels Cautery and Suture Ligature in Prevention of Postrenal Transplant Lymphocele Formation: A Randomized Controlled Trial. ⁶¹	Simforoosh N...Gholamrezaie HR	29697354	2019

Sources

Genes for Lymphocele

Genes related to Lymphocele (0 elite genes):

(show all 12)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	KLK3	Kallikrein Related Peptidase 3	Protein Coding	6.99	DISEASES inferred ¹⁵
2	CABIN1	Calcineurin Binding Protein 1	Protein Coding	6.88	DISEASES inferred ¹⁵
3	MAPK8IP1	Mitogen-Activated Protein Kinase 8 Interacting Protein 1	Protein Coding	6.44	DISEASES inferred ¹⁵
4	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	6.39	DISEASES inferred ¹⁵
5	MAPK8IP2	Mitogen-Activated Protein Kinase 8 Interacting Protein 2	Protein Coding	6.04	DISEASES inferred ¹⁵
6	PTPRN	Protein Tyrosine Phosphatase Receptor Type N	Protein Coding	5.99	DISEASES inferred ¹⁵
7	ERVMER34-1	Endogenous Retrovirus Group MER34 Member 1, Envelope	Protein Coding	5.88	DISEASES inferred ¹⁵
8	ALB	Albumin	Protein Coding	5.65	DISEASES inferred ¹⁵
9	CAGE1	Cancer Antigen 1	Protein Coding	5.64	DISEASES inferred ¹⁵
10	STK10	Serine/Threonine Kinase 10	Protein Coding	5.52	DISEASES inferred ¹⁵
11	ZNF787	Zinc Finger Protein 787	Protein Coding	5.32	DISEASES inferred ¹⁵
12	VEGFC	Vascular Endothelial Growth Factor C	Protein Coding	5.28	DISEASES inferred ¹⁵

Sources

Variations for Lymphocele

Sources

Expression for Lymphocele

Search GEO for disease gene expression data for Lymphocele.

Sources

Pathways for Lymphocele

Sources

GO Terms for Lymphocele

Biological processes related to Lymphocele according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of endocytosis	GO:0045807	9.16	MAPK8IP2 MAPK8IP1
2	receptor-mediated endocytosis	GO:0006898	9.13	MAPK8IP2 MAPK8IP1 ALB
3	regulation of JNK cascade	GO:0046328	8.62	MAPK8IP2 MAPK8IP1

Molecular functions related to Lymphocele according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	kinesin binding	GO:0019894	8.96	MAPK8IP2 MAPK8IP1
2	MAP-kinase scaffold activity	GO:0005078	8.62	MAPK8IP2 MAPK8IP1

Sources

Sources for Lymphocele

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia